hx-1171
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2012 (NCT01548391)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Loading structure…
SMILES
CCCCCCOc1cc(C)c(O)c(C)c1C- Mol. weight
- 236.35 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3182532 ↗
Also known as
- 1-o-hexyl-2,3,5-trimethylhydroquinone
- hthq-2,3,5
- hx-1171
- hx-1171
- hx-1171
- hx-1171
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01889745 | N/A | Jun 20, 2013 | Biotoxtech Co., Ltd, University of Ulsan |
| NCT01548391 | Phase 1 | Mar 1, 2012 | Biotoxtech Co., Ltd |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Biotoxtech Co., Ltd | For profit | 2 | 2 | 2 | 2012 |
| University of Ulsan | Academic/Hospital | 1 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1